American Journal of Neuroradiology 28:328-334, February 2007
© 2007 American Society of Neuroradiology
HEAD & NECK
Can Pretreatment CT Perfusion Predict Response of Advanced Squamous Cell Carcinoma of the Upper Aerodigestive Tract Treated with Induction Chemotherapy?
a Department of Radiology, University of Michigan, Ann Arbor, Mich
b Department of Otorhinoloryngology, University of Michigan, Ann Arbor, Mich
Address correspondence to Aaron Zima, MD, Department of Radiology, University of Michigan, 1500 E. Medical Center Dr, Ann Arbor, MI 48109; e-mail: ajzima{at}umich.edu
BACKGROUND AND PURPOSE: Treatment of advanced stage squamous cell carcinoma of the upper aerodigestive tract with nonsurgical organ preservation protocols demonstrates improved cure rates with fewer comorbidities compared with surgery and radiation. The purpose of this study was to prospectively assess whether pretreatment evaluation of the primary site with quantitative CT perfusion measurements predicted response to induction chemotherapy and to create a prediction model to predict the response to induction chemotherapy in future patients.
METHODS: Seventeen patients who were enrolled in a prospective trial assessing surgical intervention versus a nonsurgical protocol underwent a pretreatment CT perfusion followed by direct laryngoscopy. After induction chemotherapy, tumor response was determined by the surgeon’s estimate of tumor volume. The CT perfusion parameters were correlated with the clinical response using a Wilcoxon rank-sum analysis. A logistic regression model was used to create a prediction based on the most significant CT perfusion parameter.
RESULTS: Elevated values of blood volume (P = .004) and blood flow (P = .03) were significantly correlated with >50% reduction in tumor volume after chemotherapy. A prediction model based on tumor blood volume demonstrated 91.7% sensitivity and 80.0% specificity, with an area under the receiver operating characteristic curve of 0.95.
CONCLUSION: Our preliminary data imply that tumors with elevated blood volume and blood flow were statistically associated with response to induction chemotherapy. These results suggest that pretreatment CT perfusion may be able to identify patients who will successfully respond to induction chemotherapy, which could potentially eliminate this step for subsequent patients when deciding on the appropriate treatment regimen.
This article has been cited by other articles:
 |
|
 |
|
  L. Faggioni, E. Neri, and C. Bartolozzi CT Perfusion of Head and Neck Tumors: How We Do It Am. J. Roentgenol., January 1, 2010; 194(1): 62 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Ng, X. Wang, S. C. Faria, E. Lin, C. Charnsangavej, and N. M. Tannir Perfusion CT in Patients With Metastatic Renal Cell Carcinoma Treated With Interferon Am. J. Roentgenol., January 1, 2010; 194(1): 166 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Petralia, L. Preda, S. Raimondi, G. D'Andrea, P. Summers, G. Giugliano, F. Chiesa, and M. Bellomi Intra- and Interobserver Agreement and Impact of Arterial Input Selection in Perfusion CT Measurements Performed in Squamous Cell Carcinoma of the Upper Aerodigestive Tract AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1107 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ash, T. N. Teknos, D. Gandhi, S. Patel, and S. K. Mukherji Head and Neck Squamous Cell Carcinoma: CT Perfusion Can Help Noninvasively Predict Intratumoral Microvessel Density Radiology, May 1, 2009; 251(2): 422 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bisdas, Z. Rumboldt, J. Wagenblast, M. Baghi, T.S. Koh, M. Hambek, T.J. Vogl, and M.G. Mack Response and Progression-Free Survival in Oropharynx Squamous Cell Carcinoma Assessed by Pretreatment Perfusion CT: Comparison with Tumor Volume Measurements AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Smith, R. C. Carlos, L. R. Junck, C. I. Tsien, A. Elias, and P. C. Sundgren Developing a Clinical Decision Model: MR Spectroscopy to Differentiate Between Recurrent Tumor and Radiation Change in Patients with New Contrast-Enhancing Lesions Am. J. Roentgenol., February 1, 2009; 192(2): W45 - W52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kim, L. Loevner, H. Quon, E. Sherman, G. Weinstein, A. Kilger, and H. Poptani Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck Clin. Cancer Res., February 1, 2009; 15(3): 986 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Park, E. Klotz, M.-J. Kim, S. Y. Song, S. W. Park, S.-W. Cha, J. S. Lim, J. Seong, J. B. Chung, and K. W. Kim Perfusion CT: Noninvasive Surrogate Marker for Stratification of Pancreatic Cancer Response to Concurrent Chemo- and Radiation Therapy1 Radiology, January 1, 2009; 250(1): 110 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Park, E. Klotz, M.-J. Kim, S. Y. Song, S. W. Park, S.-W. Cha, J. S. Lim, J. Seong, J. B. Chung, and K. W. Kim Perfusion CT: Noninvasive Surrogate Marker for Stratification of Pancreatic Cancer Response to Concurrent Chemo- and Radiation Therapy Radiology, November 4, 2008; (2008) 2493080226. [Abstract] [Full Text]
|
|
|
|
|
|
S. Bisdas, K. Spicer, and Z. Rumboldt Whole-Tumor Perfusion CT Parameters and Glucose Metabolism Measurements in Head and Neck Squamous Cell Carcinomas: A Pilot Study Using Combined Positron-Emission Tomography/CT Imaging AJNR Am. J. Neuroradiol., August 1, 2008; 29(7): 1376 - 1381. [Abstract] [Full Text] [PDF]
|
|